Exact Sciences Corp EXAS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €815.25
- Day Range
- €872.00–872.00
- 52-Week Range
- €760.88–1,641.46
- Bid/Ask
- €749.00 / €872.00
- Market Cap
- €160.91 Bil
- Volume/Avg
- 1,200 / 582
Key Statistics
- Price/Earnings (Normalized)
- 535.78
- Price/Sales
- 3.53
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, or MRD, colorectal cancer screening, and multicancer screening.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 0
- Website
- https://www.exactsciences.com
Competitors
Valuation
|
Metric
|
EXAS
|
ILMN
|
MYGN
|
|---|---|---|---|
Price/Earnings (Normalized) | 535.78 | 143.71 | 522.21 |
Price/Book Value | 2.75 | 14.67 | 3.22 |
Price/Sales | 3.53 | 4.73 | 2.85 |
Price/Cash Flow | 47.15 | 54.43 | — |
Price/Earnings
EXAS
ILMN
MYGN
Financial Strength
|
Metric
|
EXAS
|
ILMN
|
MYGN
|
|---|---|---|---|
Quick Ratio | 1.81 | 0.74 | 1.44 |
Current Ratio | 2.17 | 1.11 | 1.96 |
Interest Coverage | −7.23 | −39.58 | −48.66 |
Quick Ratio
EXAS
ILMN
MYGN
Profitability
|
Metric
|
EXAS
|
ILMN
|
MYGN
|
|---|---|---|---|
Return on Assets (Normalized) | 0.13% | 1.51% | 0.46% |
Return on Equity (Normalized) | 0.26% | 2.86% | 0.70% |
Return on Invested Capital (Normalized) | 0.43% | 2.18% | 0.67% |
Return on Assets
EXAS
ILMN
MYGN
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Yndtkjggjz | Ymzv | $229.1 Bil | |||
| Danaher Corp
DHR
| Pxppxvgq | Hktlbzt | $193.5 Bil | |||
| IQVIA Holdings Inc
IQV
| Pfhtbqxz | Hjpvx | $42.2 Bil | |||
| IDEXX Laboratories Inc
IDXX
| Rkgdsbndq | Whdjh | $41.0 Bil | |||
| Agilent Technologies Inc
A
| Hhlyczxg | Dcx | $40.1 Bil | |||
| Mettler-Toledo International Inc
MTD
| Rqktcdnx | Nbvllrg | $30.1 Bil | |||
| Icon PLC
ICLR
| Ccpyfrh | Hgtgqc | $23.5 Bil | |||
| Waters Corp
WAT
| Hbllwngmrw | Kkgf | $20.2 Bil | |||
| Illumina Inc
ILMN
| Xwtyzhz | Ymklqd | $20.1 Bil | |||
| Labcorp Holdings Inc
LH
| Xtknbyttq | Kntvncn | $18.4 Bil |
United States